Literature DB >> 19886801

Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases.

Johan Maertens1, Vincent Maertens, Koen Theunissen, Wouter Meersseman, Philippe Meersseman, Stef Meers, Eric Verbeken, Gregor Verhoef, Johan Van Eldere, Katrien Lagrou.   

Abstract

BACKGROUND: Prompt diagnosis of invasive pulmonary aspergillosis (IPA) remains a challenge. Galactomannan (GM) detection in bronchoalveolar lavage (BAL) fluid by the Platelia enzyme immunoassay aims to further improve upon the test's utility by applying it directly to specimens from the target organ.
METHODS: A retrospective analysis of the Platelia assay was performed on BAL samples from 99 evaluable high-risk hematology patients, including 58 with proven or probable IPA.
RESULTS: BAL GM demonstrated an improved sensitivity profile (91.3% with an optical density [OD] index cutoff of >or=1.0) in comparison with culture and microscopy (50% and 53.3%, respectively). The diagnostic accuracy as given by the area under the receiver operating characteristic curve was 0.93 (95% confidence interval, 0.88-0.99); further decreasing the OD index cutoff to 0.5 compromised specificity more than it improved sensitivity. Estimates of the positive and negative predictive value of the Platelia assay on BAL samples (OD index, >or=1.0) were 76% and 96%, respectively. The mean BAL GM OD index was not different in neutropenic versus nonneutropenic case patients (3.9 and 4.5, respectively; P = .3); however, a trend toward decreased sensitivity in patients receiving mold-active prophylaxis was noted.
CONCLUSION: BAL GM is a valuable adjunctive diagnostic tool to other conventional microbiologic and radiologic studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19886801     DOI: 10.1086/647935

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  54 in total

Review 1.  Fungal diagnostics in pneumonia.

Authors:  Erika D Lease; Barbara D Alexander
Journal:  Semin Respir Crit Care Med       Date:  2011-12-13       Impact factor: 3.119

2.  Detection and measurement of fungal burden in a guinea pig model of invasive pulmonary aspergillosis by novel quantitative nested real-time PCR compared with galactomannan and (1,3)-β-D-glucan detection.

Authors:  Martina Lengerova; Iva Kocmanova; Zdenek Racil; Kristyna Hrncirova; Sarka Pospisilova; Jiri Mayer; Laura K Najvar; Nathan P Wiederhold; William R Kirkpatrick; Thomas F Patterson
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

3.  Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay.

Authors:  Riccardo Torelli; Maurizio Sanguinetti; Adrian Moody; Livio Pagano; Morena Caira; Elena De Carolis; Leonello Fuso; Gennaro De Pascale; Giuseppe Bello; Massimo Antonelli; Giovanni Fadda; Brunella Posteraro
Journal:  J Clin Microbiol       Date:  2011-10-19       Impact factor: 5.948

4.  Invasive pulmonary aspergillosis diagnosed by broncho-alveolar lavage.

Authors:  Michihiro Uchiyama
Journal:  BMJ Case Rep       Date:  2012-06-14

5.  Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity.

Authors:  Jorien D'Haese; Koen Theunissen; Edith Vermeulen; Hélène Schoemans; Greet De Vlieger; Liesbet Lammertijn; Philippe Meersseman; Wouter Meersseman; Katrien Lagrou; Johan Maertens
Journal:  J Clin Microbiol       Date:  2012-02-01       Impact factor: 5.948

6.  Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study.

Authors:  Greet De Vlieger; Katrien Lagrou; Johan Maertens; Eric Verbeken; Wouter Meersseman; Eric Van Wijngaerden
Journal:  J Clin Microbiol       Date:  2011-08-31       Impact factor: 5.948

7.  The Role of Biomarkers for Diagnosis of and Therapeutic Decisions Related to Invasive Aspergillosis in Children.

Authors:  Brian T Fisher
Journal:  Curr Fungal Infect Rep       Date:  2013-03-01

8.  Validation of a new Aspergillus real-time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid.

Authors:  Ga-Lai M Chong; Wendy W J van de Sande; Gijs J H Dingemans; Giel R Gaajetaan; Alieke G Vonk; Marie-Pierre Hayette; Dennis W E van Tegelen; Guus F M Simons; Bart J A Rijnders
Journal:  J Clin Microbiol       Date:  2015-01-07       Impact factor: 5.948

9.  The Prospective Antifungal Therapy Alliance(®) registry: A two-centre Canadian experience.

Authors:  Shariq Haider; Coleman Rotstein; David Horn; Michel Laverdiere; Nkechi Azie
Journal:  Can J Infect Dis Med Microbiol       Date:  2014       Impact factor: 2.471

10.  Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients.

Authors:  Li-Yang Hsu; Ying Ding; Jason Phua; Liang-Piu Koh; Douglas S Chan; Kay-Leong Khoo; Paul A Tambyah
Journal:  BMC Infect Dis       Date:  2010-03-03       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.